Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
9,06 USD | -0,98% | -4,82% | +19,47% |
23/04 | ASTRIA THERAPEUTICS, INC. : HC Wainwright maintient sa recommandation à l'achat | ZM |
09/04 | Astria Therapeutics, Inc. nomme Sunil Agarwal à son conseil d'administration | CI |
Métier
Nombre d'employés: 59
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 26/06/08 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 01/04/11 |
Chief Tech/Sci/R&D Officer | - | 15/07/22 | |
John Ruesch
PRN | Corporate Officer/Principal | - | 17/07/23 |
Keri McGrail
HRO | Human Resources Officer | - | 01/03/21 |
Andrew Komjathy
PRN | Corporate Officer/Principal | 61 | 25/09/19 |
Ben Harshbarger
LAW | General Counsel | 55 | 12/06/20 |
Andrea Matthews
PRN | Corporate Officer/Principal | - | 01/07/14 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 01/01/14 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 04/01/19 |
Director/Board Member | 75 | 05/04/16 | |
Jonathan Violin
BRD | Director/Board Member | 49 | 28/01/21 |
Jill Milne
FOU | Founder | 56 | 26/06/08 |
Hugh Cole
BRD | Director/Board Member | 59 | 26/07/19 |
Joanne Beck
BRD | Director/Board Member | 63 | 14/02/19 |
Director/Board Member | 56 | 28/01/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 54 913 061 | 48 159 943 ( 87,70 %) | 0 | 87,70 % |
Action B | 0 | 31 107 | 0 | 0 |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+19,47% | 502 M | |
-2,72% | 102 Md | |
+1,88% | 96,29 Md | |
+1,86% | 22,18 Md | |
-15,35% | 21,2 Md | |
-8,86% | 18,31 Md | |
-38,74% | 17,38 Md | |
-13,84% | 16,36 Md | |
+6,09% | 13,97 Md | |
+33,81% | 12,17 Md |
- Bourse
- Actions
- Action ATXS
- Société Astria Therapeutics, Inc.